We are delighted to invite you to the 28th World Congress on Biotechnology, scheduled to take place on June 16-17, 2025, in the vibrant city of Amsterdam, Netherlands. This premier event focuses on the transformative theme, "Biotechnology and Artificial Intelligence: A Powerful Partnership," highlighting the profound synergy between cutting-edge biotechnological innovations and AI-driven advancements.
Biotechnology 2025 provides an interdisciplinary platform for researchers, academicians, industry professionals, and policymakers to explore how artificial intelligence is revolutionizing drug discovery, gene editing, personalized medicine, agriculture, and environmental sustainability. The conference aims to foster collaborations that integrate AI algorithms with biotechnological processes, accelerating scientific discovery and product development.
Key highlights include plenary talks, expert-led workshops, and interactive sessions covering the latest breakthroughs in genomics, proteomics, bioinformatics, synthetic biology, and AI applications in biotechnology. Attendees will gain insights into emerging technologies, practical solutions, and ethical considerations shaping the future of biotech innovation.
Join us in Amsterdam, a city renowned for its scientific heritage and cultural vibrance, to connect with global experts, share knowledge, and pioneer advancements that address some of the world's most pressing challenges. Together, let’s redefine possibilities at the intersection of biotechnology and AI.
We look forward to welcoming you to Biotechnology 2025!
-
Biotechnologists
-
Molecular Biologists
-
Genetic Engineers
-
Synthetic Biologists
-
Biomedical Researchers
-
Agricultural Biotechnology Experts
-
Environmental Biotechnologists
-
Industrial Biotechnologists
-
Bioinformatics Specialists
-
AI Researchers in Biotechnology
-
Microbiologists
-
Biochemists
-
R&D Scientists in Biotech Industries
-
Academic Researchers in Biotechnology
-
Graduate and Postdoctoral Researchers
-
Biophysicists
-
Cellular and Molecular Technologists
-
Genomics Experts
-
Proteomics Specialists
-
Computational Biologists
-
Systems Biologists
-
Pharmacogenomics Researchers
-
Biomanufacturing Specialists
-
Tissue Engineers
-
Metabolic Engineers
-
Drug Discovery Scientists
-
Bioprocess Engineers
-
Epigenetics Researchers
-
Nanobiotechnology Experts
-
Vaccine and Therapeutics Developers
Be part of the future of science at the 28th World Congress on Biotechnology, happening on June 16-17, 2025, in Amsterdam, Netherlands. This global platform brings together pioneers in biotechnology and artificial intelligence to explore their transformative partnership and its vast potential.
Reasons to Attend:
-
Discover Breakthroughs: Dive into innovative sessions on AI-powered gene editing, synthetic biology, bioinformatics, and sustainable solutions.
-
Engage with Visionaries: Meet world-class researchers, industry leaders, and policymakers shaping the future of biotechnology.
-
Showcase Your Work: Present your research, receive constructive feedback, and enhance your global visibility.
-
Drive Innovation: Learn how cutting-edge AI technologies are revolutionizing drug discovery, personalized medicine, and environmental biotechnology.
Conference Benefits
-
Inspiration and Insights: Hear from influential speakers and thought leaders sharing the latest discoveries and trends.
-
Expand Your Network: Build connections with professionals from academia, industries, startups, and funding bodies.
-
Career Advancement: Enhance your skills and knowledge through hands-on workshops and discussions.
-
Recognition: Publish your research in renowned journals and compete for distinguished awards.
Join us to explore, innovate, and collaborate at Biotechnology 2025—where ideas transform into solutions for a better tomorrow !
The global biotechnology market is poised for robust growth in 2025, driven by advancements in healthcare, agriculture, and industrial applications. Valued at over $1.3 trillion, the market is expected to grow at a compound annual growth rate (CAGR) of 8-10%, propelled by innovations in genomics, synthetic biology, and biopharmaceuticals.
Key drivers include the increasing adoption of artificial intelligence (AI) in drug discovery and genetic engineering, alongside growing demand for personalized medicine and sustainable agricultural practices. The healthcare sector dominates the market, with biopharmaceuticals accounting for nearly 60% of revenue, supported by advancements in monoclonal antibodies, gene therapies, and mRNA technologies.
Agricultural biotechnology is also experiencing significant growth, with innovations in CRISPR-based gene editing and biofertilizers driving productivity and sustainability. Environmental biotechnology, focusing on bioplastics and waste management, is gaining traction due to rising environmental concerns.
Geographically, North America leads the market due to strong R&D investments, followed by Europe and Asia-Pacific, which are witnessing rapid expansion due to favorable government policies and emerging biotech startups.
With rising collaborations between biotech and AI firms, the biotechnology market is set to redefine industries, delivering breakthroughs that address global challenges in health, food security, and environmental sustainability.
-
Biotechnology Innovation Organization (BIO)
-
EuropaBio
-
American Society for Microbiology (ASM)
-
Biotechnology Industry Research Assistance Council (BIRAC)
-
BioIndustry Association (BIA) – bioindustry.org
-
BIOTECanada
-
Japan Bioindustry Association (JBA)
-
European Federation of Biotechnology (EFB)
-
Swiss Biotech Association
-
AusBiotech
